Efficacy of fluorouracil combined with paclitaxel and oxaliplatin for the treatment of advanced gastric signet ring cell carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Surg. Mar 27, 2025; 17(3): 94286
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.94286

Table 1 Comparison of clinical efficacy between the two patient groups

DCR: Disease control rate; ORR: Objective response rate; PD: Progressive disease; PR: Partial remission; SD: Stable disease.

Citation: Liu M, Feng B, He N, Yan R, Qin J. Efficacy of fluorouracil combined with paclitaxel and oxaliplatin for the treatment of advanced gastric signet ring cell carcinoma. World J Gastrointest Surg 2025; 17(3): 94286
URL: https://www.wjgnet.com/1948-9366/full/v17/i3/94286.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i3.94286

Liu M, Feng B, He N, Yan R, Qin J. Efficacy of fluorouracil combined with paclitaxel and oxaliplatin for the treatment of advanced gastric signet ring cell carcinoma. World J Gastrointest Surg 2025; 17(3): 94286 [PMID: 40162413 DOI: 10.4240/wjgs.v17.i3.94286]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.